EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Anti-SSB/La Antibodies as Predictors of Decreased Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) in Primary Sjögren Disease

Simona Caraiola, Laura Voicu, Daniela Opriș-Belinski iD, Claudia Oana Cobilinschi, Magda Ileana Pârvu, Ion Andrei Ion, Daniela Ștefana Gologanu, Răzvan Adrian Ionescu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Simona Caraiola und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Department-Internal Medicine (Cardiology, Gastroenterology, Hepatology, Rheumatology, Geriatrics), Family Medicine, Occupational Medicine, Facu…. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Carbon Monoxide, Antibodies, Antinuclear, Pulmonary Diffusing Capacity. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the University of Medicine and Pharmacy “Carol Davila” through the institutional program “Publish not Perish”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung involvement is the most common extraglandular manifestation of primary Sjögren’s Disease (pSjD). There is an increasing interest in finding the clinical/serological risk predictors of this feature. A cross-sectional study evaluating anti-SSA/Ro antibodies, anti-SSB/La antibodies, rheumatoid factor, antinuclear antibodies, and the diffusing capacity of the lungs for carbon monoxide (DLCO) in 26 pSjD patients who presented interstitial changes on the chest CT scan was performed. The titres and positivity rates for anti-SSA/Ro (p = 0.02, p = 0.02) and anti-SSB/La antibodies (p = 0.01, p = 0.001) proved to be significantly increased in patients with abnormal DLCO. Anti-SSB/La antibodies’ titres seemed to be the best predictor for decreased DLCO–AUC 0.791 (0.587–0.994), p = 0.016. A close-to-significance decrease was found in the titres (p = 0.07) and positivity rates—p = 0.09 and OR of 0.15 (0.01–1.63)—of anti-SSB/La antibodies in patients with usual interstitial pneumonia (UIP), indicating their possible protective role against UIP. The lymphocytic interstitial pneumonitis (LIP) pattern on lung CT scan was significantly associated with the simultaneous positivity of the four examined serological markers (p = 0.03). The increase in anti-SSB/La antibody positivity rate in patients with LIP patterns was situated close to the significance level (p = 0.09). Quadruple positivity, as well as isolated anti-SSB/La positivity, could be risk factors for developing LIP in pSjD patients. Thus, anti-SSB/La antibodies might represent a marker of lung involvement in pSjD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sjogren's SyndromeCarbon MonoxideAntibodies, AntinuclearPulmonary Diffusing CapacityLungHumansFemaleMiddle AgedMaleAgedCross-Sectional StudiesAdultTomography, X-Ray ComputedBiomarkersLung Diseases, Interstitial

Stichwörter der Autor:innen

anti-SSA/Ro antibodiesanti-SSB/Ro antibodiesdiffusing capacity of the lungs for carbon monoxideinterstitial lung diseaseprimary Sjögren’s Disease

Substanzen

Carbon MonoxideAntibodies, AntinuclearSS-A antibodiesBiomarkers

Autor:innen und Institutionen

  • Fifth Department-Internal Medicine (Cardiology, Gastroenterology, Hepatology, Rheumatology, Geriatrics), Family Medicine, Occupational Medicine, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 0…
  • Internal Medicine Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.
  • "Prof. Dr. C.C. Iliescu" Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania.
  • Department of Rheumatology and Internal Medicine, Sfânta Maria Clinical Hospital, 011172 Bucharest, Romania.
  • Rheumatology Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.
  • Pneumology Department, Colentina Clinical Hospital, 020125 Bucharest, Romania.

ORCID-Profile: Daniela Opriș-Belinski

Förderung

  • the University of Medicine and Pharmacy “Carol Davila” through the institutional program “Publish not Perish”

Zitieren

APA

Caraiola, S., Voicu, L., Opriș-Belinski, D., Cobilinschi, C. O., Pârvu, M. I., Ion, I. A., Gologanu, D. Ș., & Ionescu, R. A. (2025). The Role of Anti-SSB/La Antibodies as Predictors of Decreased Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) in Primary Sjögren Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125867

Vancouver

Caraiola S, Voicu L, Opriș-Belinski D, Cobilinschi CO, Pârvu MI, Ion IA, et al. The Role of Anti-SSB/La Antibodies as Predictors of Decreased Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) in Primary Sjögren Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125867

BibTeX
@article{Caraiola2025,
  author = {Caraiola, Simona and Voicu, Laura and Opriș-Belinski, Daniela and Cobilinschi, Claudia Oana and Pârvu, Magda Ileana and Ion, Ion Andrei and Gologanu, Daniela Ștefana and Ionescu, Răzvan Adrian},
  title = {The Role of Anti-SSB/La Antibodies as Predictors of Decreased Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) in Primary Sjögren Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125867}
}
Kostenlos starten →